Articles by Connect Planning Team

To achieve its full therapeutic potential, cord blood needs to be positioned as a platform technology for the development of cell and gene therapies. “Our session at Cord Blood Connect will explore how cord blood banks can diversify and expand […]

How far have we come in cord blood cell expansion technologies? Scientists at the leading edge of the research will explain their progress and what may lie ahead in a session at the Cord Blood Connect international congress.   “Many […]

Could your bank function through a military invasion? A tsunami? A nuclear accident? Hear from panelists who have prepared for and survived severe interruptions of banking operations, including military conflict and man-made and natural-disaster calamities.   Yaroslav Issakov, founder and […]

Do you have questions for the FDA? Would you like to have them answered by a top official of the U.S. Food & Drug Administration? Peter Marks, director of the FDA Center for Biologics Evaluation and Research (CBER), will welcome […]

Who has time to read all of the medical science literature concerning cord blood and perinatal tissues, especially if you aren’t a clinician or investigator? We’ve got you covered if you attend a first-time literature review session at the Cord […]